Galectin-4 has anticancer properties and has been shown to suppress colorectal cancer [56]; knockdown of it promotes tumorigenesis, and lower levels of galectin-4 expression were observed in inflamed precursor lesions of colorectal cancer [57]. This evidence concerns the gene LGALS4 and colorectal cancer.